JP2023507851A5 - - Google Patents

Info

Publication number
JP2023507851A5
JP2023507851A5 JP2022538753A JP2022538753A JP2023507851A5 JP 2023507851 A5 JP2023507851 A5 JP 2023507851A5 JP 2022538753 A JP2022538753 A JP 2022538753A JP 2022538753 A JP2022538753 A JP 2022538753A JP 2023507851 A5 JP2023507851 A5 JP 2023507851A5
Authority
JP
Japan
Prior art keywords
group
independently
butyl
nhc
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022538753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507851A (ja
JP7679090B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/051431 external-priority patent/WO2021127743A1/en
Publication of JP2023507851A publication Critical patent/JP2023507851A/ja
Publication of JP2023507851A5 publication Critical patent/JP2023507851A5/ja
Application granted granted Critical
Publication of JP7679090B2 publication Critical patent/JP7679090B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022538753A 2019-12-23 2020-12-23 置換ヒドロキシスチルベン化合物および誘導体、合成ならびにそれらの使用 Active JP7679090B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019904976 2019-12-23
AU2019904976 2019-12-23
PCT/AU2020/051431 WO2021127743A1 (en) 2019-12-23 2020-12-23 Substituted hydroxystilbene compounds and derivatives synthesis and uses thereof

Publications (3)

Publication Number Publication Date
JP2023507851A JP2023507851A (ja) 2023-02-27
JP2023507851A5 true JP2023507851A5 (enExample) 2024-01-09
JP7679090B2 JP7679090B2 (ja) 2025-05-19

Family

ID=76572821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538753A Active JP7679090B2 (ja) 2019-12-23 2020-12-23 置換ヒドロキシスチルベン化合物および誘導体、合成ならびにそれらの使用

Country Status (12)

Country Link
US (2) US12459883B2 (enExample)
EP (1) EP4081500A4 (enExample)
JP (1) JP7679090B2 (enExample)
KR (1) KR20220151159A (enExample)
CN (1) CN115485259A (enExample)
AU (2) AU2020415711B2 (enExample)
BR (1) BR112022012584A2 (enExample)
CA (1) CA3162498A1 (enExample)
IL (1) IL294179B2 (enExample)
MX (1) MX2022007874A (enExample)
PH (1) PH12022551548A1 (enExample)
WO (1) WO2021127743A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115536530B (zh) * 2022-10-10 2024-08-30 浙江大学 一种Vulgarisin型四环二萜化合物的化学全合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030018800A (ko) 2001-08-31 2003-03-06 주식회사 프로메디텍 시토크롬 피450 1비1 억제활성을 갖는 페닐환 유도체 및약학적으로 허용가능한 그의 염, 그의 제조방법 및 이를함유하는 조성물
US8198302B2 (en) * 2003-02-28 2012-06-12 Oxigene, Inc. Compositions and methods with enhanced therapeutic activity
US9185909B2 (en) * 2007-09-17 2015-11-17 The Trustees Of Columbia University In The City Of New York Synthesis of resveratrol-based natural products
SG194582A1 (en) 2011-05-04 2013-12-30 Univ Sydney Prenylated hydroxystilbenes
CN103172512B (zh) * 2011-12-23 2016-08-03 中国医学科学院医药生物技术研究所 一组木豆素结构类似化合物、制备方法和应用
CN107011127A (zh) * 2017-04-21 2017-08-04 聊城大学 一种含氟基团的白藜芦醇衍生物及制备方法和用途

Similar Documents

Publication Publication Date Title
ES2960953T3 (es) Forma de sal de clorhidrato para la inhibición de EZH2
JP2023505288A (ja) Erk阻害剤としてのチアゾロラクタム系化合物およびその使用
US20190210997A1 (en) Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
US20200352894A1 (en) Combination therapy
JP2019529444A5 (enExample)
AU2017341769B2 (en) N-Acylethanolamide derivatives and uses thereof
CN112930214A (zh) 含氘化合物
ES2704951T3 (es) Compuesto precursor de marcaje radioactivo y método para producir un compuesto marcado con flúor radioactivo utilizando el compuesto precursor
WO2013007184A1 (zh) 抗肿瘤药物四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用
JP7214925B2 (ja) Pan-RAFキナーゼ阻害剤としてのビアリール化合物
JP2022539126A (ja) ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用
KR20230065303A (ko) 벤즈아미드계 화합물 및 이의 용도
JP2019505548A (ja) Mycモジュレーターとしてのmaxバインダーおよびこれらの使用
KR20240012513A (ko) 세스퀴테르펜 유도체, 그의 약학적 조성물 및 그의 제조 방법과 용도
EP3181554A1 (en) Quinazoline derivative
WO2019141009A1 (zh) 一种化合物及其在药学上的应用
JP2019523230A (ja) 抗転移性2H‐セレノフェノ[3,2‐h]クロメン、それらの合成、および同薬剤の使用方法
CA2987067A1 (en) Compounds and methods for treating cancer
JP4933683B1 (ja) 細胞毒性特性及び/または抗血管新生特性を有する新規なレチノイド誘導体
WO2022179469A1 (zh) 噻吩并嘧啶二酮类化合物及其应用
JPWO2001027115A1 (ja) 五環性タキサン化合物
CN108473449B (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途
US10093609B2 (en) TAK1 kinase inhibitors, compositions, and uses related thereto
WO2022122042A1 (zh) 阿比特龙衍生物及其制备方法
WO2023224128A1 (ja) 線維症の治療又は予防のための医薬組成物